XJPX
4912
Market cap3.06bUSD
Oct 09, Last price
1,768.50JPY
1D
1.14%
1Q
5.80%
Jan 2017
-7.89%
Name
Lion Corp
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Headquartered in Tokyo, Japan, and established in 1891, Lion Corporation is a global manufacturer and distributor of an extensive range of consumer and industrial products. Its operations are organized into three primary divisions: Consumer Products Business, Industrial Products Business, and Overseas Business. The company offers a broad portfolio of consumer goods, including a full spectrum of dental and oral hygiene items such as toothpastes, toothbrushes, and mouthwashes, alongside diverse personal care staples like shampoos, body washes, skin treatments, and deodorants. Lion also provides various over-the-counter medicinal products, spanning analgesics, eye care solutions, cold and flu remedies, gastrointestinal medications, and vitamin supplements. Its household and kitchen essentials encompass laundry detergents, fabric softeners, general cleaning supplies, and dishwashing liquids. Furthermore, it supplies nutritional supplements and functional beverages. Within its industrial division, Lion manufactures specialized chemical compounds. These range from rubber processing additives, insulating oils, and concrete admixtures to ground improvement agents, surfactants, and cosmetic components, among others. Additionally, the company provides pet supplies and bespoke gift selections.
Key people
Chairman of the Board of Directors, Independent Director · since 2025
Masayuki Takemori
Executive President, Chief Executive Officer, Representative Director · since 2024
Kengo Fukuda
Executive Vice President, Representative Director · since 2025
Hitoshi Suzuki
Executive Vice President, Representative Director · since 2025
Masaharu Mikuni
Senior Executive Officer, Chief Director of Health & Home Care Sales · since 2018
Fumitomo Noritake
Senior Executive Officer, Director · since 2023
Yasuhiro Urao
Senior Executive Officer, Chief Director of Health & Home Care Business · since 2025
Yoshihiro Aihara
Executive Officer, Chief Director of Northeast Asia Business · since 2024
Masahide Arai
Executive Officer, Director of Business Planning, Director Incharge of Group Strategic Collaboration, Director Incharge of Group Strategic Collaboration in Southeast and South Asia Business Unit · since 2025
Katsuhiko Chikyu
Executive Officer, Chief Director of Purchasing · since 2023
Go Ichitani
Executive Officer, Chief Director of Southeast and South Asia Business, Senior Director of Business · since 2025
Annette Ling
Executive Officer · since 2025
Kei Minamikawa
Executive Officer, Chief Director of Supply Chain Planning · since 2024
Atsushi Naito
Executive Officer, Chief Director of Research and Development · since 2025
Norihiko Nakabayashi
Executive Officer · since 2024
Eiji Nishinaga
Executive Officer, Director of Sustainability Promotion · since 2025
Tomomichi Okano
Executive Officer · since 2023
Takashi Saegusa
Executive Officer, Chief Director of Production Logistics, Director of Administration · since 2025
Yasutsugu Shimizu
Executive Officer, President of Subsidiary · since 2025
Akihiko Takeo
Executive Officer, Director of Accounting · since 2023
Headquarters & legal address
台東区蔵前1丁目3番28号
東京都, 13 111-8644
JP
東京都, 13 111-8644
JP
Other language
Lion Corporation
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||